MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$14,820,815
EPS
-$0.4
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
12,007,300
16,720,362
8,035,969*
6,291,171
General and administrative
2,370,412
1,291,820
1,099,647*
1,143,804
Total operating expenses
14,377,712
18,012,182
9,135,616
7,434,975
Operating loss
-14,377,712
-18,012,182
-9,135,616*
-7,434,975
Interest income
160,233
137,800
183,493*
152,317
Other financing costs
1,589,336
-
-
-
Change in fair value of warrants
986,000
268,000
322,000*
20,000
Total other income (expense), net
-443,103
405,800
505,493*
172,317
Net loss
-14,820,815
-17,606,382
-8,630,123
-7,262,658
Basic EPS
-0.4
-0.63
-0.384
-0.37
Diluted EPS
-0.4
-0.63
-0.384
-0.37
Basic Average Shares
37,518,778
27,847,884
22,484,689
19,685,071
Diluted Average Shares
37,518,778
27,847,884
22,484,689
19,685,071
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$14,820,815
(-138.27%↓ Y/Y)
Operating loss
-$14,377,712
(-129.26%↓ Y/Y)
Total other income
(expense), net
-$443,103
(-962.15%↓ Y/Y)
Change in fair value of
warrants
$986,000
(804.29%↑ Y/Y)
Interest income
$160,233
(-16.28%↓ Y/Y)
Total operating
expenses
$14,377,712
(129.26%↑ Y/Y)
Other financing costs
$1,589,336
Research and development
$12,007,300
(132.61%↑ Y/Y)
General and
administrative
$2,370,412
(113.64%↑ Y/Y)
Buy us a coffee
Annovis Bio, Inc. (ANVS)
Annovis Bio, Inc. (ANVS)